"Ascitic Fluid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The serous fluid of ASCITES, the accumulation of fluids in the PERITONEAL CAVITY.
| Descriptor ID |
D001202
|
| MeSH Number(s) |
A12.207.119
|
| Concept/Terms |
Ascitic Fluid- Ascitic Fluid
- Ascitic Fluids
- Fluid, Ascitic
- Fluids, Ascitic
- Peritoneal Fluid
- Fluid, Peritoneal
- Fluids, Peritoneal
- Peritoneal Fluids
- Peritoneal Effusion
- Effusion, Peritoneal
- Effusions, Peritoneal
- Peritoneal Effusions
|
Below are MeSH descriptors whose meaning is more general than "Ascitic Fluid".
Below are MeSH descriptors whose meaning is more specific than "Ascitic Fluid".
This graph shows the total number of publications written about "Ascitic Fluid" by people in this website by year, and whether "Ascitic Fluid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 0 | 2 | 2 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ascitic Fluid" by people in Profiles.
-
Ascitic Fluid Analysis Leading to the Diagnosis of Constrictive Pericarditis in 2 Patients. J Investig Med High Impact Case Rep. 2022 Jan-Dec; 10:23247096221097530.
-
Ovarian cancer cell-derived lysophosphatidic acid induces glycolytic shift and cancer-associated fibroblast-phenotype in normal and peritumoral fibroblasts. Cancer Lett. 2019 02 01; 442:464-474.
-
Protective and recuperative effects of 3-bromopyruvate on immunological, hepatic and renal homeostasis in a murine host bearing ascitic lymphoma: Implication of niche dependent differential roles of macrophages. Biomed Pharmacother. 2018 Mar; 99:970-985.
-
Multiplex profiling identifies distinct local and systemic alterations during intraperitoneal chemotherapy for ovarian cancer: An NRG Oncology/Gynecologic Oncology Group Study. Gynecol Oncol. 2017 07; 146(1):137-145.
-
Malignant ascites enhances migratory and invasive properties of ovarian cancer cells with membrane bound IL-6R in vitro. Oncotarget. 2016 Dec 13; 7(50):83148-83159.
-
Multiscale tumor spatiokinetic model for intraperitoneal therapy. AAPS J. 2014 May; 16(3):424-39.
-
Diagnostic accuracy of interleukin-6 levels in peritoneal fluid for detection of endometriosis. Arch Gynecol Obstet. 2013 Oct; 288(4):805-14.
-
Serum and peritoneal evaluation of vitamin D-binding protein in women with endometriosis. Postepy Hig Med Dosw (Online). 2008 Mar 03; 62:103-9.
-
A novel technique for the enrichment of primary ovarian cancer cells. Am J Obstet Gynecol. 2007 Nov; 197(5):507.e1-5.
-
Differential flow cytometric detection of intracellular cytokines in peripheral and peritoneal mononuclear cells of women with endometriosis. Eur J Obstet Gynecol Reprod Biol. 2008 Mar; 137(1):67-76.